We are pleased to announce the publication of a new chapter titled "Exploring Animal Models for Interstitial Cystitis/Bladder Pain Syndrome" by our research associate, Dr. Tadeja Kuret, in IntechOpen.
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic inflammatory disease of the urinary bladder that presents significant challenges in diagnosis and treatment. Patients typically experience discomfort, pain, increased urinary frequency, urgency, and nocturia. Unfortunately, current treatment options primarily focus on alleviating symptoms, with no single solution offering long-term benefits for all patients. This limitation stems from the complex, multifactorial nature of IC/BPS and the still-evolving understanding of its pathobiology.
Dr. Kuret's chapter emphasizes the critical role of preclinical studies using animal models in advancing our knowledge of IC/BPS. These models are essential for investigating the disease’s etiology and pathophysiology, discovering new drug targets, and designing effective clinical trials. The chapter discusses various animal models developed to replicate the primary symptoms and complex mechanisms of IC/BPS, highlighting the strengths and weaknesses of each.
Given the complexity of IC/BPS and the presence of distinct clinical subtypes, it is unlikely that a single animal model can capture all aspects of the syndrome. Instead, the development and application of multiple models tailored to specific subtypes will be necessary. Dr. Kuret stresses the importance of understanding the unique underlying mechanisms of each subtype and the therapeutic mechanisms being studied. This understanding is vital for translating preclinical findings into successful clinical outcomes.
We encourage you to read this insightful chapter to gain a deeper understanding of the challenges and future directions in IC/BPS research.
Congratulations to Dr. Tadeja Kuret for this significant contribution to the field!
Comments